Diagnostics ecosystem co-developer

As a diagnostics ecosystem co-developer, we adhere to the spirit of being open and collaborative, and strive to build an efficient, inclusive and sustainable diagnostics ecosystem. Our total solutions include open-system instruments, reagent services and core raw materials. We are dedicated to integrating upstream and downstream resources, accelerating the conversion from innovation to application, and introducing groundbreaking diagnostics solutions to global healthcare. To date, we have installed over 7,500 open-system instruments. Together with over 250 global ecosystem partners, we have made the industry a more open and inclusive arena for resource-sharing.

Comprehensive layout for industrial upgrading

  • Complete raw materials development and supply
  • Open and stable instruments
  • AI-driven target discovery and biomarker validation
g1_bg01.png

As a key domestic supplier with one of the most comprehensive portfolios of diagnostics raw materials, we provide high-quality raw materials covering a range of morbidities and methodologies to help our customers increase their competitiveness and enrich product lines.

Our instruments, which span chemiluminescence immunoassay (CLIA), ultra-fast PCR, fluorescence-based lateral flow immunoassay and high-throughput sequencing, are efficient, universally adaptable, stable and open, helping customers reduce expenditure and development costs and accelerate product launch.

Our novel biomarker discovery and validation logic are empowered by advanced multi-omics and AI algorithms. Additionally, our novel macromolecule design and targeted evolution platform can help our customers achieve First-in-Class, Best-in-Class in their respective fields.

Open collaboration for mutual benefit

Our fundamental technologies are open to partners. Our total solutions cover novel biomarker discovery, open-system instruments and omni-dimensional market support, which work together to establish an IVD platform-based ecosystem where upstream, midstream and downstream partners can enjoy mutual benefits via strategic collaborations.

  • Upstream innovation support

    Effective innovation incubation, data integration and joint research lead to the creation of an efficient ecosystem that bridges the gap between clinical needs and innovative results and helps researchers translate their work into tangible results.

  • Midstream open platform

    Our open-system instruments, shared interfaces, and methods and processes contribute to efficient reagent development for our partners.

  • Downstream channel system

    We help our partners expand their market reach by connecting clinical laboratories and leveraging market resources, technologies and capital.

g1_img01.svg
g1_bg02.png

Customized services for addressing needs

We are customer-centric. As such, our comprehensive and customized services are dedicated to building an open, synergistic, win-win ecosystem that aids our partners in stacking up against competition.

  • For developers/R&D institutions
  • For manufacturers
  • For distributors

Partnerships for a shared future

We have an extensive history of driving innovation in the IVD industry through close collaboration with many well-known companies in China and abroad. We look forward to working together with more and new partners for the promising future of the IVD industry.

  • 7500+

    open-system instruments installed

  • 250+

    global ecosystem partners

  • 200+

    collaboration projects

Join us for a better future of IVD.

If you have any question or need any support, please fill out the information below.

nav_img.png